Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Nueva formulación de un medicamento genérico para el tratamiento de la dislipidemia

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOTR20150731001
Publicado:
16/02/2016
Caducidad:
16/02/2017
Resumen:
Un académico de un centro de investigación universitario de Turquía ha desarrollado una nueva formulación de un medicamento para reducir los efectos secundarios de rosuvastatina disminuyendo la dosis del medicamento. Esta formulación se caracteriza por su alta actividad farmacocinética y biodisponibilidad. La universidad busca socios para continuar con el desarrollo de la formulación y establecer acuerdos de investigación. El socio buscado debe contribuir poniendo a disposición sus instalaciones de investigación. La universidad busca financiación para comercializar el medicamento.

Details

Tittle:
A super generic drug formulation for dyslipidemia treatment.
Summary:
An academician from a university research center located in Izmir/Turkey has developed a new drug formulation aimed to reduce side effects of rosuvastatin by reducing the drug dose. The university is looking for partners for further development of the formulation, under research cooperation agreement. It is expected from the interested partner to contribute by means of utilizing its research facilities. Financial support for commercialisation of drug formulation is requested.
Description:
Coronary heart disease (CHD) is the most common cause of death in the world and its incidence is increasing
day by day. Hyperlipidemia is the most important risk factor for coronary heart disease and statins are the most commonly used drug group in treatment of this. Statin molecules are used for dyslipidemia (high cholesterol) treatment and the tablet forms of statins has low oral bioavailability. The invention is about a new drug formulation of rosuvastatin molecule and the aim is increased bioavailability action. Different type of drug delivery system was used and generated the new drug formulation.

This present invention is aimed to reduce side effects of rosuvastatin by reducing the drug dose and also it is
expected to increase patient compliance. The new pharmaceutical form is intended to be presented to the
pharmaceutical industry and to be implemented on dyslipidemia patients by developing formulation with
these advantages.

The university is looking for partners for further development of the formulation stage, to perform clinical research under research cooperation agreement. It is expected from the partner to contribute by means of utilizing its research facilities. Financial support for commercialisation of drug formulation is requested.
Advantages and Innovations:
-Reducing side effects in patients
-Quick response of treatment
-Low dosage usage and high efficiency
-High pharmacokinetic activity
-Bioavailability is high (through to peak ratio is approximately 1)
-Super generic form
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
International patent application is made with Patent Cooperation Treaty. Search report has already came and waiting for the country selection.

Partner sought

Type and Role of Partner Sought:
- Type of partner sought:
Pharmeceutical industry, R-Y-D centre or universities

- Task to be performed by the partner sought:
Financial support for commercialisation of drug formulation is requested. Support in research of the drug is also requested.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Keywords

Technology Keywords:
06001015 Productos farmacéuticos / medicamentos